Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

4 Stocks To Watch: AKCA, CGC, CREE, PI

Published 05/29/2018, 11:58 PM
Updated 07/09/2023, 06:31 AM

Akcea Therapeutics, Inc. (NASDAQ:AKCA), one of our swing trades, had a nice day on Tuesday, jumping 1.56, or 6.7%, to 24.85, on 327,223 shares traded. Not huge volume, but the best in about six sessions. A move like this that pops to resistance, and I want to see if there’s a follow-through. The declining tops were taken out, the moving averages are crossing over, and any move above Tuesday’s high at 25, or so, and we should see 29, maybe even 33-34.

Canopy Growth Corporation (NYSE:CGC) is setting up a big base for a massive move. That’s my thinking anyhow. It didn’t make me happy the last couple days, but Tuesday was a positive session, up 1.20, or 4.46%, to 28.10, on 2.6 million shares traded. The volume excelled, not as huge as the day before, but I’ll take the 26 million shares. The bottom line is that I would like to see it hold 26-7 ideally, with a stop under 25 1/2, or 24.80. Resistance is 31 1/2. The targets are 33-4, and then the mid-to-high 30’s, maybe 37.

Cree, Inc. (NASDAQ:CREE) popped out and ran to the highest level in four years to 48.00. It was up 1.47, or 3.21%, to 47.32, on 1.9 million shares on Tuesday. If the rising channel is met, the targets are 52 and 59 going forward.

Swing trade Impinj, Inc. (NASDAQ:PI) is acting great, I think, because the bottom has been put in, in my opinion. It formed a breakaway gap, a falling wedge, and on Tuesday it had a beautiful pop of 2.34, or 14%, to 19.08, on 1.4 million shares. I think it has more to go. Targets are 23 and 27.

Stocks on the long side included Akcea Therapeutics, Inc. (NASDAQ:AKCA), Bilibili Inc. (NYSE:BILI), Canopy Growth Corporation (NYSE:CGC), Intelsat S.A. (NYSE:I), Pharmaceuticals, Inc. (NASDAQ:CPRX), Cree, Inc. (NASDAQ:CREE), Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), Carvana Co. (NYSE:CVNA), Cryoport, Inc. (NASDAQ:CYRX), DocuSign, Inc. (NASDAQ:DOCU), Endocyte, Inc. (NASDAQ:ECYT), Evolus, Inc. (NASDAQ:EOLS), Intelsat S.A. (I), Momo Inc. (NASDAQ:MOMO), Micron Technology, Inc. (NASDAQ:MU), Myriad Genetics, Inc. (NASDAQ:MYGN), New York & Company, Inc. (NYSE:NWY), Impinj, Inc. (NASDAQ:PI), Quotient Limited (NASDAQ:QTNT), Square, Inc. (NYSE:SQ), Savara Inc. (NASDAQ:SVRA), TechTarget, Inc. (NASDAQ:TTGT), and Twitter, Inc. (NYSE:TWTR).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.